Safety and immunogenicity of a randomized phase I prime-boost trial with ALVAC-HIV (vCP205) and gp160 MN/LAI-2 adjuvanted in alum or polyphosphazene

被引：0

作者：

RJ O'Connell

VR Polonis

S Ratto-Kim

J Cox

LL Jagodzinski

J Malia

NL Michael

J Excler

ML Robb

JH Kim

机构：

[1] U.S.Military HIV Research Program,

[2] International AIDS Vaccine Initiative,undefined

来源：

Retrovirology | / 9卷

关键词：

Primary Isolate; Vaccine Recipient; Chromium Release; Adjuvanting Strategy; Boost Regimen;

D O I：

暂无

中图分类号：

学科分类号：

摘要：

引用